We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$204M
2
TSM icon
TSMC
TSM
+$94.9M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$58M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$23M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$17.9M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$52.8M
2
AAPL icon
Apple
AAPL
+$32.5M
3
MSFT icon
Microsoft
MSFT
+$16.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$14.5M
5
DIS icon
Walt Disney
DIS
+$14.2M

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
METC icon
2201
Ramaco Resources Class A
METC
$666M
$70K ﹤0.01%
8,223
-14,090
-63% -$132K
MRVI icon
2202
Maravai LifeSciences
MRVI
$861M
$70K ﹤0.01%
4,999
+2,863
+134% +$41.1K
NE icon
2203
Noble Corp
NE
$7.07B
$70K ﹤0.01%
1,768
+1,255
+245% +$50.2K
PMT
2204
PennyMac Mortgage Investment
PMT
$828M
$70K ﹤0.01%
5,650
+1,961
+53% +$26.4K
RILY icon
2205
BRC Group Holdings
RILY
$303M
$70K ﹤0.01%
2,476
-10,932
-82% -$414K
BAM icon
2206
Brookfield Asset Management
BAM
$89.3B
$69K ﹤0.01%
2,110
-6,356
-75% -$206K
CTMX icon
2207
CytomX Therapeutics
CTMX
$730M
$69K ﹤0.01%
45,351
+12,248
+37% +$27.7K
DXC icon
2208
DXC Technology
DXC
$1.8B
$69K ﹤0.01%
2,690
-3,118
-54% -$85K
HPP
2209
Hudson Pacific Properties
HPP
$786M
$69K ﹤0.01%
1,496
+345
+30% +$22.2K
MOV icon
2210
Movado Group
MOV
$796M
$69K ﹤0.01%
2,420
+2,306
+2,023% +$78.1K
OGN icon
2211
Organon & Co
OGN
$3.6B
$69K ﹤0.01%
2,927
-1,565
-35% -$42K
SPCE icon
2212
Virgin Galactic
SPCE
$475M
$69K ﹤0.01%
843
+315
+60% +$31.4K
TIGO icon
2213
Millicom
TIGO
$15.8B
$69K ﹤0.01%
3,645
+3,268
+867% +$56.9K
TRMK icon
2214
Trustmark
TRMK
$2.8B
$69K ﹤0.01%
2,795
+1,888
+208% +$55.8K
WNS
2215
DELISTED
WNS Holdings
WNS
$69K ﹤0.01%
741
+338
+84% +$29.4K
B
2216
DELISTED
Barnes Group Inc.
B
$69K ﹤0.01%
1,715
+1,258
+275% +$53K
TRHC
2217
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$69K ﹤0.01%
12,400
+8,377
+208% +$47.9K
RETA
2218
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$69K ﹤0.01%
760
+327
+76% +$19.2K
AESI icon
2219
Atlas Energy Solutions
AESI
$1.47B
$68K ﹤0.01%
+4,001
New +$65.7K
CBZ icon
2220
CBIZ
CBZ
$2.97B
$68K ﹤0.01%
1,367
+190
+16% +$9.15K
FSM icon
2221
Fortuna Silver Mines
FSM
$3.11B
$68K ﹤0.01%
17,708
-8,458
-32% -$30.1K
GGAL icon
2222
Galicia Financial Group
GGAL
$7.22B
$68K ﹤0.01%
6,158
+5,520
+865% +$68.3K
MTRN icon
2223
Materion
MTRN
$5.91B
$68K ﹤0.01%
587
+531
+948% +$53.2K
OUT icon
2224
Outfront Media
OUT
$5.25B
$68K ﹤0.01%
4,244
+2,599
+158% +$45.5K
PRGS icon
2225
Progress Software
PRGS
$1.84B
$68K ﹤0.01%
1,177
-780
-40% -$43.5K
87 88
89
90 91

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.